<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-EOB-2091</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2091</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Повышение уровня BSF-2 в сыворотке крови больных с вирусом гепатита B</article-title><trans-title-group xml:lang="en"><trans-title>Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8988-5957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давуд</surname><given-names>Али А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dawood</surname><given-names>Ali A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор философии Микробиология, лектор, кафедра анатомии</p><p>Аль-Джамеа, 1, Мосул</p></bio><bio xml:lang="en"><p>Ph.D. Microbiology, Lecturer, Department of Anatomy</p><p>Al-Jameaa, st.1, Mosul</p></bio><email xlink:type="simple">aad@uomosul.edu.iq</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Альтобье</surname><given-names>Махмуд А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Altobje</surname><given-names>Mahmood A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор философии Иммунология, доцент, кафедра биологии, Колледж наук</p><p>Аль-Джамеа, 1, Мосул</p></bio><bio xml:lang="en"><p>Ph.D. Immunology, Associate Professor, Department of Biology</p><p>Al-Jameaa, st.1, Mosul</p></bio><email xlink:type="simple">mahtsbio30@uomosul.edu.iq</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аль-Ррассам</surname><given-names>Зейад Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Alrassam</surname><given-names>Zeyad T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор философии Микробиология, преподаватель, кафедра биофизики</p><p>Аль-Джамеа, 1, Мосул</p></bio><bio xml:lang="en"><p>Ph.D. Microbiology, Lecturer, Department of Biophysics</p><p>Al-Jameaa, st.1, Mosul</p></bio><email xlink:type="simple">dr.zeyadalrassam@uomosul.edu.iq</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинский колледж Мосульского университета</institution><country>Ирак</country></aff><aff xml:lang="en"><institution>College of Medicine, University of Mosul</institution><country>Iraq</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>26</day><month>02</month><year>2021</year></pub-date><volume>23</volume><issue>1</issue><fpage>87</fpage><lpage>94</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Давуд А.А., Альтобье М.А., Аль-Ррассам З.Т., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Давуд А.А., Альтобье М.А., Аль-Ррассам З.Т.</copyright-holder><copyright-holder xml:lang="en">Dawood A.A., Altobje M.A., Alrassam Z.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2091">https://www.mimmun.ru/mimmun/article/view/2091</self-uri><abstract><p>Справочная информация: Гепатит В - основная инфекция пораженной печени человека. Воспаление печени, вызванное вирусами гепатита, может привести к циррозу и гепатоцеллюлярной карциноме. Фактор стимуляции В-клеток 2 (BSF-2) является одним из цитокинов, влияющих на регуляцию и дифференциацию иммунного ответа человека. Цель: этот отчет направлен на оценку уровней BSF-2, GPT и GOT в сыворотке крови пациентов с различными стадиями гепатита B по сравнению со здоровым контролем. Методы. В этом исследовании участвовало 52 пациента, предположительно с острыми и хроническими заболеваниями, у которых обнаружен HBsAg. BSF-2 был обнаружен с помощью анализа ELISA. Биохимические показатели определяли с помощью комплектов автоматического анализатора. Для статистического анализа использовалось программное обеспечение SPSS версии 16. Результаты. У пациентов с острым гепатитом В уровень BSF-2 повышен больше, чем при хроническом гепатите B. Уровни GPT и GOT повышены в группе острого гепатита больше, чем в группе хронического гепатита. Мы сообщили о значительном значении между уровнями BSF-2, GOT и GPT. Мы не оценивали связь между возрастом пациента и группами случаев гепатита. Заключение: наши данные подтверждают повышение уровня BSF-2 при повышении уровня GOT больше, чем уровень GPT при остром гепатите B. Уровни BSF-2, GPT и GOT варьируются в зависимости от течения острого и хронического HBV. Мы предположили, что повышение уровня BSF-2 указывает на повреждение печени у пациентов с острым HBV.</p></abstract><trans-abstract xml:lang="en"><p>Background: Hepatitis B is the main infection of the injured liver for humans. Inflammation of the liver is caused by hepatitis viruses may lead to cirrhosis and hepatocellular carcinoma. The B-cell stimulatory factor 2 (BSF-2) is one of the cytokines that affect the regulation and differentiation of the human immune response. Objective: this report aims to estimate the BSF-2, GPT, and GOT levels in patients’ serum with different stages of hepatitis B compared with healthy control. Methods: This study assessed 52 patients presumably with acute and chronic cases who have HBsAg positive. BSF-2 was detected using ELISA assay. Biochemical parameters were determined using kits of an automated analyzer. SPSS version-16 software was used for statistical analysis. Results: Acute hepatitis B patients had shown elevation in BSF-2 level more than of chronic hepatitis B. GPT and GOT levels elevated in the acute hepatitis group more than of the chronic hepatitis group. We reported a significant value between BSF-2, GOT, and GPT levels. We didn’t score an association between patient’s age and cases groups of hepatitis. Conclusion: our data confirmed increasing of BSF-2 levels with the increase of GOT level more than GPT level with acute hepatitis B. BSF-2, GPT and GOT levels are varied in different courses of acute and chronic HBV. We surmised that the elevation of BSF-2 levels designates liver injury of patients with acute HBV.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ELISA</kwd><kwd>GPT</kwd><kwd>GOT</kwd><kwd>BSF-2</kwd><kwd>HBsAg</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ELISA</kwd><kwd>GPT</kwd><kwd>GOT</kwd><kwd>BSF-2</kwd><kwd>HBsAg</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Lastly, we send thanks to the blood bank center and Ibn-Alatheer teaching hospital for providing serum samples. We also send thankful to the University of Mosul.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Alestig E. Geographic and genetic diversity of hepatitis B., M.Sc. thesis in microbiology, University of Gothenburg, 2011.</mixed-citation><mixed-citation xml:lang="en">Alestig E. Geographic and genetic diversity of hepatitis B., M.Sc. thesis in microbiology, University of Gothenburg, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Behnaz R., Zahurin M., Yamunah A., Noor S., Rosmawati M. Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population. Biomed. Rep., 2018, Vol. 9, pp. 213-220.</mixed-citation><mixed-citation xml:lang="en">Behnaz R., Zahurin M., Yamunah A., Noor S., Rosmawati M. Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population. Biomed. Rep., 2018, Vol. 9, pp. 213-220.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Caixia X., Yanning L., Zhi C., Min Z. Involvement of Interleukin 6 in Hepatitis B Viral Infection. Cell. Physiol. Biochem., 2015, Vol. 37, pp. 677-686.</mixed-citation><mixed-citation xml:lang="en">Caixia X., Yanning L., Zhi C., Min Z. Involvement of Interleukin 6 in Hepatitis B Viral Infection. Cell. Physiol. Biochem., 2015, Vol. 37, pp. 677-686.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chih-Yung Y., Tzu-Hsing K., Ling-Pai T. Human Hepatitis B Viral e Antigen Interacts with Cellular Interleukin-1 Receptor Accessory Protein and Triggers Interleukin-1 Response. J. Biol. Chem., 2006, Vol. 281, no. 45, pp. 34525–34536.</mixed-citation><mixed-citation xml:lang="en">Chih-Yung Y., Tzu-Hsing K., Ling-Pai T. Human Hepatitis B Viral e Antigen Interacts with Cellular Interleukin-1 Receptor Accessory Protein and Triggers Interleukin-1 Response. J. Biol. Chem., 2006, Vol. 281, no. 45, pp. 34525–34536.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dawood A.A., Altobje M.AA. Correlation between CXCL-motif-10 and IFN-γ on Hemodialysis Patients with HCV under Treatment. Int. J. Emerg. Technol., 2019, Vol. 10, Iss. 3, pp. 208-215.</mixed-citation><mixed-citation xml:lang="en">Dawood A.A., Altobje M.AA. Correlation between CXCL-motif-10 and IFN-γ on Hemodialysis Patients with HCV under Treatment. Int. J. Emerg. Technol., 2019, Vol. 10, Iss. 3, pp. 208-215.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Genglin Z., Ting Z., Qiyi Z., Chan X., Jing L., Liang P., Zhiliang G. Overproduction of IL-27 may play a proinflammatory role in HBV infected patients with severe liver and inflammation. Int. J. Clin. Exp. Med., 2016, Vol. 9, no. 3, pp. 7000-7007.</mixed-citation><mixed-citation xml:lang="en">Genglin Z., Ting Z., Qiyi Z., Chan X., Jing L., Liang P., Zhiliang G. Overproduction of IL-27 may play a proinflammatory role in HBV infected patients with severe liver and inflammation. Int. J. Clin. Exp. Med., 2016, Vol. 9, no. 3, pp. 7000-7007.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gora-G B., Anna L., Wies A., Szyd O., Wanda B., Maria K. Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon-alpha Magdalena. Ann. Hepatol., 2003, Vol. 2, no. 2, pp. 92-97.</mixed-citation><mixed-citation xml:lang="en">Gora-G B., Anna L., Wies A., Szyd O., Wanda B., Maria K. Serum interleukin 6 and interleukin 12 levels in children with chronic hepatitis HBV treated with interferon-alpha Magdalena. Ann. Hepatol., 2003, Vol. 2, no. 2, pp. 92-97.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hong-Me C., Hong-Le L., Yu-Cong Y., Xiao-Li C., Yue-Fei W., Fan-Fan X., Ying-Ren Z. Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure. Exp. Ther. Med., 2014, Vol. 7, pp. 1013-1019.</mixed-citation><mixed-citation xml:lang="en">Hong-Me C., Hong-Le L., Yu-Cong Y., Xiao-Li C., Yue-Fei W., Fan-Fan X., Ying-Ren Z. Serum IL-21 levels associated with chronic hepatitis B and hepatitis B-related liver failure. Exp. Ther. Med., 2014, Vol. 7, pp. 1013-1019.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Horvat R.T. Diagnostic and Clinical Relevance of HBV Mutations. Lab. Med., 2011, Vol. 42, no. 8, pp. 488-496.</mixed-citation><mixed-citation xml:lang="en">Horvat R.T. Diagnostic and Clinical Relevance of HBV Mutations. Lab. Med., 2011, Vol. 42, no. 8, pp. 488-496.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hyodo N., Nakamura I., Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin. Exp. Immunol., 2004,Vol. 135, pp. 462-466.</mixed-citation><mixed-citation xml:lang="en">Hyodo N., Nakamura I., Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin. Exp. Immunol., 2004,Vol. 135, pp. 462-466.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kazumichi A., Atsushi T., Hiromichi I., Manabu H., Ken O., Yukiko K., Hiroshi W., Hiromasa O. Interleukin21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springer Plus, 2016, Vol. 5, no. 1, 777. doi: 10.1186/s40064-016-2512-y.</mixed-citation><mixed-citation xml:lang="en">Kazumichi A., Atsushi T., Hiromichi I., Manabu H., Ken O., Yukiko K., Hiroshi W., Hiromasa O. Interleukin21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis. Springer Plus, 2016, Vol. 5, no. 1, 777. doi: 10.1186/s40064-016-2512-y.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ke W., Zhe-bin W., Yi-nong Y., Jing L., Geng-lin Z., Yu-jie S., Hong-liang H., Yu-bao Z., Zhi-liang G. Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Hepat. Mon., 2014, Vol. 14, no. 7, e19370. doi: 10.5812/hepatmon.19370.</mixed-citation><mixed-citation xml:lang="en">Ke W., Zhe-bin W., Yi-nong Y., Jing L., Geng-lin Z., Yu-jie S., Hong-liang H., Yu-bao Z., Zhi-liang G. Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Hepat. Mon., 2014, Vol. 14, no. 7, e19370. doi: 10.5812/hepatmon.19370.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lamiaa N.H., Sahar M.A., Fetouh S.H., Walid A.M., Mona F.S. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis? J. Immunotoxicol., 2013, Vol. 10, no. 4, pp. 380-386.</mixed-citation><mixed-citation xml:lang="en">Lamiaa N.H., Sahar M.A., Fetouh S.H., Walid A.M., Mona F.S. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis? J. Immunotoxicol., 2013, Vol. 10, no. 4, pp. 380-386.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.K., Bettencourt R., Brenner D. Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo Study. PLoS ONE, 2012, Vol. 7, no. 4, e34218. doi: 10.1371/journal.pone.0034218.</mixed-citation><mixed-citation xml:lang="en">Lee J.K., Bettencourt R., Brenner D. Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo Study. PLoS ONE, 2012, Vol. 7, no. 4, e34218. doi: 10.1371/journal.pone.0034218.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Marzieh A., Saleh S., Majid S. Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran. Asian Pac. J. Cancer Prev., 2016, Vol. 17, pp. 2395-2399.</mixed-citation><mixed-citation xml:lang="en">Marzieh A., Saleh S., Majid S. Interleukin-6-174 Promoter Polymorphism and Susceptibility to Hepatitis B Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Iran. Asian Pac. J. Cancer Prev., 2016, Vol. 17, pp. 2395-2399.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Min S., Jue W., Jinbin D., Wenying M., Jiali M., Ting W., Na W., Yugang W. Interleukins-10 and 18 Genes Polymorphisms in Hepatitis B Virus-Infected Saudi Patients. Mol. Med. Rep., 2014, Vol. 11, pp. 121-126.</mixed-citation><mixed-citation xml:lang="en">Min S., Jue W., Jinbin D., Wenying M., Jiali M., Ting W., Na W., Yugang W. Interleukins-10 and 18 Genes Polymorphisms in Hepatitis B Virus-Infected Saudi Patients. Mol. Med. Rep., 2014, Vol. 11, pp. 121-126.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pisit T., Thosporn V., Apiradee T., Pinit K., Pongspeera S., Yong P. Serum Interleukin-6 and Interferon-gamma Levels in Patients with Hepatitis B Associated Chronic Liver Disease. Asian Pac. J. Allergy Immunol., 2000, Vol. 18, pp. 109-114.</mixed-citation><mixed-citation xml:lang="en">Pisit T., Thosporn V., Apiradee T., Pinit K., Pongspeera S., Yong P. Serum Interleukin-6 and Interferon-gamma Levels in Patients with Hepatitis B Associated Chronic Liver Disease. Asian Pac. J. Allergy Immunol., 2000, Vol. 18, pp. 109-114.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Qiao-Ling S., Wei R. Review of cytokine profiles in patients with hepatitis. World J. Gastroenterol., 2004, Vol. 10, no. 12, pp. 1709-1715.</mixed-citation><mixed-citation xml:lang="en">Qiao-Ling S., Wei R. Review of cytokine profiles in patients with hepatitis. World J. Gastroenterol., 2004, Vol. 10, no. 12, pp. 1709-1715.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Roli S., Yogesh K.C., Indu V., Jyotdeep K. Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population. Indian J. Med. Res., 2014, Vol. 139, pp. 737-745.</mixed-citation><mixed-citation xml:lang="en">Roli S., Yogesh K.C., Indu V., Jyotdeep K. Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population. Indian J. Med. Res., 2014, Vol. 139, pp. 737-745.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Seyed H., Hosseini K., Foroogh N., Mohammad A.D. Serum Levels of Interleukin-4, Interleukin-10, and Interferonin Patients with Chronic Hepatitis B Infection. Hepat. Mon., 2018, Vol. 18, no. 4, e60377. doi: 10.5812/hepatmon.60377.</mixed-citation><mixed-citation xml:lang="en">Seyed H., Hosseini K., Foroogh N., Mohammad A.D. Serum Levels of Interleukin-4, Interleukin-10, and Interferonin Patients with Chronic Hepatitis B Infection. Hepat. Mon., 2018, Vol. 18, no. 4, e60377. doi: 10.5812/hepatmon.60377.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shu-Ling H., Ji-Guang Z., Zhen-Li W., Shuai G., Kai W. Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection. BMC Infect. Dis., 2016, Vol. 16, 200. doi: 10.1186/s12879-016-1543-x.</mixed-citation><mixed-citation xml:lang="en">Shu-Ling H., Ji-Guang Z., Zhen-Li W., Shuai G., Kai W. Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection. BMC Infect. Dis., 2016, Vol. 16, 200. doi: 10.1186/s12879-016-1543-x.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Shubham S., Anupam M., Ranjit R., Ratna R. Hepatitis C Virus Induces Interleukin-1 (IL-1)/IL-18 in Circulatory and Resident Liver Macrophages. J. Virol., 2018, Vol. 87, pp. 12284-12290.</mixed-citation><mixed-citation xml:lang="en">Shubham S., Anupam M., Ranjit R., Ratna R. Hepatitis C Virus Induces Interleukin-1 (IL-1)/IL-18 in Circulatory and Resident Liver Macrophages. J. Virol., 2018, Vol. 87, pp. 12284-12290.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tian L., Lei C., Long W., Yu-Feng Y. IL-6 Plays a Crucial Role in HBV Infection. J. Clin. Transl. Hepatol., 2015, Vol. 3, pp. 271-276.</mixed-citation><mixed-citation xml:lang="en">Tian L., Lei C., Long W., Yu-Feng Y. IL-6 Plays a Crucial Role in HBV Infection. J. Clin. Transl. Hepatol., 2015, Vol. 3, pp. 271-276.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Xing-Jiu H., Yang-Kyu., Hyung-Soon I., Oktay Y., Euisik Y., Hak-Sung K. Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques. Sensors, 2006, Vol. 6, pp. 756-782.</mixed-citation><mixed-citation xml:lang="en">Xing-Jiu H., Yang-Kyu., Hyung-Soon I., Oktay Y., Euisik Y., Hak-Sung K. Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques. Sensors, 2006, Vol. 6, pp. 756-782.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
